Publications
26
Citations
149
Est. group size
~5
Recurring co-author estimate
Active years
15
Publishing since 2012
Typically publishes in teams of ~8 · 38% small-team papers (≤3 authors) · across 11 venues
- GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
Obesity Science & Practice · 2026
- A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management
Obesity Pillars · 2026
- Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
Preventive Medicine Reports · 2025
- Coverage Checker: A Web-Based Tool to Navigate Diabetes Coverage and Prior Authorization
The Annals of Family Medicine · 2025
- Leveraging clinical decision support system tools for childhood overweight/obesity management
BMC Medical Informatics and Decision Making · 2025
- Leveraging Clinical Decision Support System Tools for Childhood Overweight/Obesity Management
Research Square · 2025
- A Primary Care–Based Weight Navigation Program
JAMA Network Open · 2024
- Supporting faculty development for obesity education: A National Survey of United States family medicine residency programme directors
Clinical Obesity · 2024
- GLP-1 RAs and SGLT2-Is to Lower Glucose and Reduce the Risk of Cardiovascular and Diabetic Kidney Disease
The Journal of the American Board of Family Medicine · 2024
- Is Prediabetes Overdiagnosed? No: A Clinician’s Perspective
The Annals of Family Medicine · 2024
- Review for "Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study"
2024
- Review for "Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study"
2024
- 1692-P: Designing and Testing a Novel Weight Navigation Program to Improve Obesity Treatment in Primary Care Settings
Diabetes · 2023
- Implications of the FAST Protocol Beyond Spirituality
The Annals of Family Medicine · 2020
- “It's Better in a Group Anyway”: Patient Experiences of Group and Individual Acupuncture
The Journal of Alternative and Complementary Medicine · 2018
- The Annals of Family Medicine×3
- The Journal of Alternative and Complementary Medicine×2
- JAMA Network Open×1
- Preventive Medicine Reports×1
- Clinical Obesity×1
- Anna McEvoy
Medicine · University of Michigan
- Jane E. Chargot
Medicine · University of Michigan
- Alisa P. Young
Medicine · University of Michigan
- Anna Laurie
Medicine · University of Michigan
- Julie Prussack
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile